{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:11:03Z","timestamp":1779300663246,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.7759\/cureus.109300","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:58:02Z","timestamp":1779299882000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of Antibody Testing and Vaccination in Paediatric Recurrent Acute Otitis Media"],"prefix":"10.7759","author":[{"given":"Karim","family":"Awad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Jeffry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Molluru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huw","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Heward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2024.0053","article-title":"Incidence, antimicrobial prescribing practice, and associated healthcare costs of paediatric otorrhoea in primary care in the UK: a longitudinal population study","volume":"75","author":"Heward E","year":"2025","unstructured":"Heward E, Domzaridou E, Gavan SP, et al.. Incidence, antimicrobial prescribing practice, and associated healthcare costs of paediatric otorrhoea in primary care in the UK: a longitudinal population study. Br J Gen Pract. 2025, 75:e113-21. 10.3399\/BJGP.2024.0053","journal-title":"Br J Gen Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215121001924","article-title":"Recurrent acute otitis media: a survey of current management in England","volume":"135","author":"Hampton T","year":"2021","unstructured":"Hampton T, Whitehall E, Beasley C, et al.. Recurrent acute otitis media: a survey of current management in England. J Laryngol Otol. 2021, 135:855-7. 10.1017\/S0022215121001924","journal-title":"J Laryngol Otol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s004310100754","article-title":"The microbiologic and immunologic basis for recurrent otitis media in children","volume":"160","author":"Faden H","year":"2001","unstructured":"Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001, 160:407-13. 10.1007\/s004310100754","journal-title":"Eur J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000069759.79176.e1","article-title":"Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?","volume":"22","author":"Leibovitz E","year":"2003","unstructured":"Leibovitz E, Satran R, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?. Pediatr Infect Dis J. 2003, 22:509-15. 10.1097\/01.inf.0000069759.79176.e1","journal-title":"Pediatr Infect Dis J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1028872","article-title":"Acute otitis media","volume":"127","author":"Atkinson H","year":"2015","unstructured":"Atkinson H, Wallis S, Coatesworth AP. Acute otitis media. Postgrad Med. 2015, 127:386-90. 10.1080\/00325481.2015.1028872","journal-title":"Postgrad Med"},{"key":"ref6","unstructured":"National Institute for Health and Care Excellence (NICE). NICE clinical knowledge summaries. Scenario: recurrent acute otitis media. (2025). Accessed: May 19, 2026: https:\/\/cks.nice.org.uk\/topics\/otitis-media-acute\/management\/recurrent-acute-otitis-media\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.09.036","article-title":"Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children","volume":"118","author":"Kamchaisatian W","year":"2006","unstructured":"Kamchaisatian W, Wanwatsuntikul W, Sleasman JW, Tangsinmankong N. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol. 2006, 118:1336-41. 10.1016\/j.jaci.2006.09.036","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-025-01894-z","article-title":"Antibiotic treatment of acute and recurrent otitis media in children: an Italian intersociety consensus","volume":"51","author":"Castelli Gattinara G","year":"2025","unstructured":"Castelli Gattinara G, Bergamini M, Simeone G, et al.. Antibiotic treatment of acute and recurrent otitis media in children: an Italian intersociety consensus. Ital J Pediatr. 2025, 51:50. 10.1186\/s13052-025-01894-z","journal-title":"Ital J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-023-04918-0","article-title":"The effect of pneumococcal conjugated vaccines on occurrence of recurrent acute otitis media among infants diagnosed with acute otitis media at an age younger than 2\u00a0months","volume":"182","author":"Ziv O","year":"2023","unstructured":"Ziv O, Adelson D, Sadeh R, et al.. The effect of pneumococcal conjugated vaccines on occurrence of recurrent acute otitis media among infants diagnosed with acute otitis media at an age younger than 2\u00a0months. Eur J Pediatr. 2023, 182:2873-9. 10.1007\/s00431-023-04918-0","journal-title":"Eur J Pediatr"},{"key":"ref10","unstructured":"Pneumococcal vaccine. (2023). Accessed. May 19, 2026: https:\/\/www.nhs.uk\/vaccinations\/pneumococcal-vaccine\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00438-8","article-title":"Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3\u2008+\u20080 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study","volume":"22","author":"Swarthout TD","year":"2022","unstructured":"Swarthout TD, Henrion MY, Thindwa D, et al.. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3\u2008+\u20080 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study. Lancet Infect Dis. 2022, 22:1737-47. 10.1016\/S1473-3099(22)00438-8","journal-title":"Lancet Infect Dis"},{"key":"ref12","unstructured":"Haemophilus influenzae type b (Hib). (2023). Accessed. May 19, 2026: https:\/\/www.nhs.uk\/conditions\/hib\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00524-3","article-title":"Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine","volume":"22","author":"M\u00e4kel\u00e4 PH","year":"2003","unstructured":"M\u00e4kel\u00e4 PH, K\u00e4yhty H, Leino T, Auranen K, Peltola H, Ekstr\u00f6m N, Eskola J. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine. 2003, 22:287-92. 10.1016\/S0264-410X(03)00524-3","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00031-8","article-title":"The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine","volume":"21","author":"McIntosh ED","year":"2003","unstructured":"McIntosh ED, Conway P, Willingham J, Lloyd A. The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine. Vaccine. 2003, 21:2564-72. 10.1016\/S0264-410X(03)00031-8","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18179159","article-title":"Effect of distraction intervention for needle-related pain and distress in children: a systematic review and meta-analysis","volume":"18","author":"Cho MK","year":"2021","unstructured":"Cho MK, Choi MY. Effect of distraction intervention for needle-related pain and distress in children: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021, 18:9159. 10.3390\/ijerph18179159","journal-title":"Int J Environ Res Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450723-the-role-of-antibody-testing-and-vaccination-in-paediatric-recurrent-acute-otitis-media","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:58:05Z","timestamp":1779299885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450723-the-role-of-antibody-testing-and-vaccination-in-paediatric-recurrent-acute-otitis-media"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.109300","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}